Pentwater Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-564,714	Closed	-$42.5M	–	144
2022 Q2	$42.5M	Buy	+564,714	New	+$42.5M	0.5%	31
2019 Q4	–	Sell	-15,000	Closed	-$564K	–	143
2019 Q3	$564K	Buy	+15,000	New	+$564K	0.01%	87